Use of FDG PET to evaluate hyperbaric oxygen therapy for bisphosphonate-related osteonecrosis of the jaw.
Yamazaki
Yutaka
Y
Oral Diagnosis and Medicine, Graduate School of Medicine, Hokkaido University, Kita-ku, Sapporo, Japan. yutaka8@den.hokudai.ac.jp
Kitagawa
Yoshimasa
Y
Hata
Hironobu
H
Abe
Takahiro
T
Murai
Chika
C
Shiga
Tohru
T
Tamaki
Nagara
N
D000369:Aged, 80 and over; D004164:Diphosphonates / Q000494:pharmacology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D006931:Hyperbaric Oxygenation; D007568:Jaw / Q000000981:diagnostic imaging*; D008297:Male; D010020:Osteonecrosis / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000628:therapy*; D049268:Positron-Emission Tomography; D016896:Treatment Outcome
D004164:Diphosphonates; D019788:Fluorodeoxyglucose F18